EastPharma Ltd. reported revenue results for the nine months of 2012. For the period, the company reported revenue of USD 170.8 million, down 14.1% from the same period in 2011 of USD 198.8 million. EastPharma's sales decrease was driven by decreased volumes in DEVA's Human Pharma Products businesses.